UK's Ban on Puberty Blockers

The United Kingdom has temporarily banned the prescription of puberty blockers for minors experiencing gender dysphoria, pending further review of medical evidence by 2027. This decision follows the release of the Cass Review, which highlighted that the evidence supporting such treatments was inconclusive and posed safety risks. A notable reaction from detransitioner Chloe Cole indicates that although this ban is a significant step, it should encompass all forms of medical intervention for gender transition to truly protect children. Without a comprehensive ban, minors could simply transition to cross-sex hormones or surgeries bypassing the blockers altogether.